CatalystPit

CLLSCellectis S.A.

NASDAQ · Biological Products, (No Diagnostic Substances)
Last close $1.51 · 2026-09-30
ABOUT
ExchangeNASDAQ
SectorHealthcare
IndustryBiological Products, (No Diagnostic Substances)
INSTITUTIONAL OWNERSHIP
Institutional holders28
Shares held9,484,327
Value$28.45M
Percent of shares outstanding13.22%
As of quarter end2026-06-30
RECENT NEWS
  • CLLS: INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cellectis S.A. - CLLS
  • Cellectis discusses strategic transformation and gene editing pipeline
  • CLLS halted · Volatility pause (LULD)
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS